Researchers

Dr. Sergio Borgia is an Infectious Diseases Physician, Infection Prevention and Control Consultant and Researcher at William Osler Health System. His clinical and research expertise includes infection prevention, multidrug-resistant bacteria, viral hepatitis, and tuberculosis.

Dr. Borgia completed medical training at Queen’s University, graduate studies in Molecular Genetics and Microbiology at the University of Toronto and Mount Sinai Hospital, and specialty training in Internal Medicine and Infectious Diseases at McMaster University. He is a Fellow of the Royal College of Physicians of Canada and serves as an Assistant Clinical Professor at McMaster University.

His research includes clinical trials, viral hepatitis care models, Hepatitis Delta treatment, tuberculosis care and work related to national elimination strategies. As an ORIHI senior scientist, Dr. Borgia contributes expertise in infectious diseases, clinical research, population health, and collaborative academic program development.

Dr. Herbert Brill is a clinician scholar in pediatric gastroenterology whose research addresses evidence gaps in general pediatrics, neonatal jaundice, celiac disease, pediatric liver disease and inflammatory bowel disease.

Dr. Brill practices Pediatric Gastroenterology at William Osler Health System and Hepatology and Advanced Endoscopy at McMaster Children’s Hospital. He holds academic appointments at the University of Toronto, McMaster University and Toronto Metropolitan University.

As Chair of Osler’s Research Ethics Board and an active researcher, Dr. Brill brings both scientific leadership and strong research governance expertise to ORIHI. His work includes collaborative multi-centre studies, student-supported research and projects focused on improving evidence-informed pediatric care.

Dr. Teresa Chan is an emergency physician, internationally recognized education scientist and academic leader. She is Dean of the Toronto Metropolitan University School of Medicine and brings extensive expertise in medical education, digital scholarship, innovation, and health professions education.

Her scholarly work has focused on advancing how health professionals learn, collaborate and translate evidence into practice. As an ORIHI senior scientist, Dr. Chan contributes leadership in medical education research, digital innovation, mentorship and interdisciplinary scholarship. Her appointment strengthens ORIHI’s capacity to connect clinical care, education and research in ways that support learners, clinicians and the communities Osler serves.

Dr. Parneet Cheema is a medical oncologist, health system leader, and senior scientist at the Osler Research Institute for Health Innovation. She serves as Medical Director of Cancer Care and Head of Cancer Research at William Osler Health System, where she leads the strategic advancement of oncology care, research and innovation.

An internationally recognized expert in lung cancer, precision medicine and immunotherapy, Dr. Cheema completed her postgraduate medical training at the University of Toronto and holds a Master of Biotechnology. Her work bridges clinical care, science, and innovation.

Dr. Cheema has played a major role in transforming cancer care delivery at Osler, including through the development of the Osler Cancer Immunotherapy Program and expanded access to clinical trials. Her research focuses on real-world evidence, genomics, personalized cancer care and accelerating the translation of novel therapies into clinical practice.

Dr. Paula Chidwick is Director of Ethics at William Osler Health System and a senior scientist with the Osler Research Institute for Health Innovation. Her work focuses on advancing ethical practice, quality improvement and innovative responses to complex challenges in health care.

Dr. Chidwick holds a PhD in Philosophy with a specialization in Bioethics from the University of Guelph. She was the inaugural Director of Ethics at Osler and the first person to hold such a role in a community hospital setting in Canada. She is also the founding Director of Osler’s Ethics Quality Improvement Lab.

Her scholarly and applied work has focused on ethics quality improvement, health care consent, transitions in care and end-of-life decision-making. She has contributed to national and international work in health care ethics and has helped build collaborative networks that support ethically grounded, system-relevant research.

Dr. Shy Amlani is an Interventional Cardiologist and Physician Lead for Cardiovascular Research at William Osler Health System. He previously served as Medical Director of the Cardiac Procedures Unit and has helped advance cardiac quality improvement and interventional cardiology innovation at Osler.

His research focuses on improving outcomes in coronary artery disease, acute myocardial infarction, heart failure and complex percutaneous coronary intervention. He has contributed to clinical trials, real-world cardiovascular studies and research focused on improving cardiovascular care pathways.

As an ORIHI scientist, Dr. Amlani is helping advance cardiovascular research at Osler through clinical trials, heart failure and chronic disease work, knowledge translation and collaboration with internal and external partners. His work supports more precise, efficient, and evidence-informed cardiovascular care close to home.

Dr. Natasha Chandok is a Gastroenterologist and Hepatologist at William Osler Health System. Her work reflects a strong commitment to digestive health, liver disease and evidence-informed clinical care.

As an ORIHI scientist, Dr. Chandok brings expertise in hepatology and gastroenterology that supports practice-relevant inquiry, prevention-focused care and improved outcomes for the diverse communities Osler serves. Her appointment strengthens ORIHI’s growing community of clinician researchers and contributes to academic research growth in digestive and liver health.

Dr. Masud Khandaker is Division Head of Cardiology and Medical Director of the Cardiovascular Health System at William Osler Health System. He joined Osler in 2016 as a staff cardiologist and has held several leadership roles across ambulatory and diagnostic cardiology, cardiac rehabilitation, echocardiography and cardiology services at Peel Memorial.

Dr. Khandaker completed a PhD in Microbiology and Immunology at Western University and received his medical degree from the National University of Ireland. He completed internal medicine and cardiology residency training at the Mayo Clinic, followed by fellowship training in advanced cardiac imaging.

His clinical and research interests include complex valve disease, cardiomyopathies, pericarditis, spontaneous coronary artery dissection and cardio-oncology. As an ORIHI scientist, Dr. Khandaker is working to develop an Osler Cardiovascular Research Network that will strengthen cardiovascular research, partnerships, and knowledge translation for the communities Osler serves.

Dr. Rosa Marticorena is Manager of the Clinical Research Program at the Osler Research Institute for Health Innovation. She supports the planning, execution and operational excellence of research across William Osler Health System.

As a principal investigator and co-investigator in national and international studies, Dr. Marticorena brings clinical insight, epidemiological training and trial leadership experience to research that advances patient care. Her work bridges research infrastructure and applied clinical inquiry, helping strengthen ORIHI’s capacity to support high-quality studies, interdisciplinary collaboration and innovation.

Her research and leadership activities span clinical research operations, cardiology, nephrology, critical care, nursing and clinical research, and program development. As an ORIHI scientist, she contributes to building research systems that support evidence-informed care and improved outcomes.

Dr. Marc Ossip is Chief of Radiology and Medical Director of Diagnostic Imaging at William Osler Health System. He completed medical school and diagnostic radiology residency at the University of Toronto, followed by fellowship training in Interventional Radiology.

Dr. Ossip has played a key leadership role in advancing radiology operations, informatics, enterprise imaging systems and artificial intelligence integration. His work includes implementation and optimization of PACS and reporting workflows, as well as participation in governance initiatives focused on responsible AI deployment and clinical integration.

His research interests include imaging utilization, health system performance, artificial intelligence in radiology, lung cancer screening, diagnostic decision-making and innovation in diagnostic care. As an ORIHI scientist, Dr. Ossip contributes expertise at the intersection of imaging, oncology, digital innovation, and health systems research.

Dr. Marco Iafolla is a Medical Oncologist at William Osler Health System and an investigator with the Osler Research Institute for Health Innovation. His research focuses on advancing precision oncology and improving how clinicians identify which therapies are most likely to benefit individual patients.

His work includes the study of biomarkers such as circulating tumour DNA, or ctDNA, to support less invasive monitoring and more individualized treatment decisions. He is also involved in research related to emerging personalized cancer therapies, including mRNA-based cancer vaccine approaches.

Through his clinical and scholarly work, Dr. Iafolla contributes to cancer research that supports more precise, effective, and individualized care for patients. His work also strengthens Osler’s capacity to participate in innovative oncology research and clinical trials close to home.

Amrutha Kumar is a Professional Practice Leader for Nursing whose work as a researcher is grounded in practice-based inquiry and health system innovation. Her research focuses on nursing practice, supply chain, digital technology, workforce innovation and operational excellence.

She holds a Master of Health Management from McMaster University and is a Certified Health Executive and Certified Professional in Healthcare Quality. She also serves on statutory committees with the College of Nurses of Ontario and holds an Adjunct Faculty appointment with the Lawrence S. Bloomberg Faculty of Nursing at the University of Toronto.

Her scholarly work explores emerging technologies in clinical environments, optimization of nursing roles, and sustainable models of care. As an ORIHI investigator, she contributes to research and innovation focused on workforce development, health systems improvement, quality, patient safety and academic partnerships.

Dr. Alexandra Binnie is a critical care physician and a leading figure in ICU research. Alongside her clinical duties, Dr. Binnie holds the position of Invited Assistant Professor at the University of Algarve and serves as an intensivist at the Centro Hospitalar Universitário do Algarve in Portugal. Her expertise lies in the pathophysiology of sepsis and multiple organ dysfunction syndrome, particularly focusing on the role of epigenetics in driving the inflammatory response to infection.

Dr. Binnie's dedication to advancing critical care extends beyond the bedside. She is a co-founder of the Canadian Community ICU Research Network (CCIRNet), a pioneering initiative aimed at bolstering research capabilities in community ICUs across Canada. In her role as co-chair of CCIRNet, Dr. Binnie has been instrumental in developing the community hospital research toolkit, an accessible resource designed to facilitate the establishment and maintenance of research programs in community hospitals.

With a passion for knowledge-sharing and a commitment to enhancing research opportunities beyond Osler's walls, Dr. Binnie's contributions have made a significant impact on critical care research both domestically and internationally. Her multifaceted approach to patient care, education, and research underscores her status as a leader in the field, driving advancements in critical care medicine and fostering collaboration within the health care community.

Dr. Henry Conter is solving seemingly impossible problems in health care by reshaping how individuals engage with their health care journeys, ultimately improving outcomes. Currently serving as the Portfolio Manager of Early Development Oncology within the Pharmaceuticals Research and Early Discovery division at Hoffman La-Roche, Dr. Conter spearheads clinical trial designs that prioritize the needs of patients, clinicians, and their advocates. He also maintains an active role as a practicing General Medical Oncologist/Hematologist at Osler.

Prior to his tenure at Roche, Dr. Conter gained a track record marked by innovation and leadership excellence. Holding pivotal roles such as Chief of Hematology/Oncology, Medical Director of the Cancer Health System, and Executive Medical Director of Quality, Patient Safety, and Health System Integration at Osler, he led transformative initiatives that elevated standards of care. He also represented oncology interests on influential panels like the Ontario Steering Committee for Cancer Drugs and the pan-Canadian Oncology Drug Review Expert Review Panel, as well as serving on various advisory bodies.

Dr. Conter's academic journey underscores his multidisciplinary approach to health care. After earning his undergraduate degree in Mechanical Engineering from the University of Western Ontario, he pursued his passion for medicine, obtaining his MD from McMaster University. He then completed his clinical residency in Internal Medicine at the University of Alberta, where he earned an MSc in Health Technology Assessment. Dr. Conter further honed his expertise through a clinical fellowship in Medical Oncology at the University of Texas M.D. Anderson Cancer Center, coupled with a Masters in Finance from the University of Houston.

Throughout his career, Dr. Conter has continuously expanded his knowledge and skill set through a commitment to ongoing education. His impressive list of certifications and continuing education endeavors reflects his dedication to staying current with emerging trends and best practices in health care leadership, management, and innovation.

In addition to his professional responsibilities, Dr. Conter has played integral roles in numerous administrative and service capacities, contributing significantly to organizations like Hoffman-La Roche, Osler, and various health care committees and associations. His honours include prestigious awards from renowned institutions, affirming his commitment to excellence in patient care and health care advancement.

With a relentless drive to tackle complex healthcare challenges and a steadfast dedication to improving patient outcomes, Dr. Henry Conter continues to be a transformative force in the field of oncology and even beyond.

Dr. Shaan Dudani is a Medical Oncologist with Osler and an Assistant Professor in the Department of Medicine at the University of Toronto. He treats patients with genitourinary and gastrointestinal malignancies and serves as the GI oncology site lead at Osler. He completed medical school at the University of Birmingham in the United Kingdom followed by Internal Medicine and Medical Oncology residencies at the University of Ottawa. He then pursued a two-year clinical and research fellowship in genitourinary oncology at the Tom Baker Cancer Centre and University of Calgary and completed a Master’s in Public Health from the Harvard University T.H. Chan School of Public Health.

In the field of cancer research, Dr. Dudani has contributed through his involvement in clinical trials and outcomes research. As the local principal investigator for various gastrointestinal trials, he plays an important role in advancing treatment options for patients. His research interests include health outcomes and effectiveness research using real-world data, with a focus on cancers such as kidney, rectal, and lung cancers. Dr. Dudani has also made significant contributions to biomarker development for personalized treatments for patients.

Throughout his career, Dr. Dudani has been recognized for his outstanding contributions to oncology. His honours include awards such as the Novartis Oncology Young Canadian Investigator Award and American Society of Clinical Oncology Conquer Cancer Foundation Merit Awards.

As a clinician, researcher, and educator, Dr. Shaan Dudani is committed to excellence in cancer care and helping to shape his clinical practice with the latest research.

Dr. Tina Hu is a dedicated family physician based in Toronto, known for her commitment to patient-centered care, research, and advocacy for marginalized populations. Having completed her medical degree, residency, and Master of Science degree at the University of Toronto, Dr. Hu has established herself in the field of family medicine, with a particular interest in addiction medicine and caring for vulnerable communities.

Dr. Hu's outstanding contributions to research have been recognized with many awards, including the 2018 University of Toronto Postgraduate Medical Education Postgraduate Research Award and the Family Medicine Resident Award from The College of Family Physicians of Canada. Her research endeavors focus on improving health outcomes and quality of care for patients, with projects ranging from delirium management in elderly patients to telepsychiatry services for children and adolescents in remote areas of Ontario.

In her award-winning research within The General Medicine Inpatient Initiative, Dr. Hu investigated delirium and transitions of care, aiming to enhance communication between inpatient and outpatient physicians and develop delirium-specific discharge recommendations. Through her work, she sought to address the under-recognition of delirium in the medical community and improve outcomes for patients during high-risk transitions of care.

Additionally, Dr. Hu's worked on a telepsychiatry program evaluation highlights her commitment to providing accessible mental health services to underserved communities, particularly remote Indigenous populations. Her innovative approach utilizes telemedicine to deliver urgent psychiatric consultations, reducing the need for travel and improving access to care for vulnerable youth.

Dr. Hu's passion for family medicine stems from her desire to make a meaningful difference in the lives of her patients and communities. Her experiences working with marginalized populations, both during her undergraduate studies and as the executive director of IMAGINE, a student-run interprofessional clinic, have shaped her dedication to addressing social determinants of health and advocating for equitable access to health care.

Driven by a deep appreciation for primary care and the opportunity to build long-term relationships with patients, Dr. Hu believes in the transformative power of family medicine in promoting preventive healthcare and addressing the diverse needs of individuals and communities. Her commitment to compassionate, comprehensive care exemplifies her dedication to improving health outcomes and advancing the field of family medicine.

Dr. Hina Marsonia is an innovative pharmacist with a wide range of clinical expertise and a commitment to advancing patient care through innovative research and education. Currently serving as the Clinical Pharmacist for the complex medicine clinic at Osler, Dr. Marsonia has been active in pioneering initiatives that integrate technology to enhance chronic disease management.

Dr. Marsonia earned her Doctorate of Pharmacy from the University of Colorado and holds a Bachelor of Science in Pharmacy from the University of Toronto. She has been an active member of various professional organizations over the years including the Canadian Hospital Society for Pharmacists, Ontario College of Pharmacist Professional Practice Committee.

Standing out amongst her accomplishments is her leadership in developing and implementing a remote management platform for patients with chronic diseases. The platform includes real-time clinical decision support tools designed to empower patients in self-management, foster engagement, and improve communication between healthcare providers and patients. Dr. Marsonia's work addresses a critical gap in managing comorbidities between scheduled clinical appointments, particularly in complex settings like the complex medicine clinic. This platform is now being used across multiple organizations and community programs such as with paramedicine teams to manage patients with congestive heart failure and chronic obstructive pulmonary disease.

Dr. Marsonia's dedication to research and education extends beyond her clinical roles. As a Residency Coordinator, she mentors pharmacy residents, guiding them through pharmacy research projects and manuscript development. Dr. Marsonia’s commitment to patient safety and healthcare quality is apparent as one of the academic leads of the Best Possible Medication History Process in Surgery project. In addition to her research, Dr. Marsonia has authored several publications and presented at conferences such as the e-Health Conference and the Global Summit Health Ecosystem Panel Discussion. In 2019, she participated in the India Global Health Team to enhance research and information exchange related to diabetes care.

Dr. Marsonia received the Chanderkalli Chatoori Award of Excellence Professional Practice Award in 2024, highlighting her leadership and innovation in pharmacy practice and she continues to drive advancements.

Theresa Nitti, RPN, serves as the Provincial PoET (Prevention of Error-based Transfers) Program Coordinator at Osler, bringing with her a wealth of experience from various health care settings. With a background spanning family practice, supportive housing, adult day programs, long-term care, and hospital environments, Theresa's expertise is vast and diverse.

At Osler, Theresa has held nursing positions on both Palliative and General Medicine units, where she facilitated multiple safety and quality improvement initiatives. Her journey then led her to become the Spread Leader for the PoET Southwest Spread Project, a collaborations between Osler’s Ethics Quality Improvement Lab and McMaster University’s Department of Family Medicine.

Theresa's dedication to advancing health care ethics is evident through her contributions to various projects and initiatives. She presented at the World Congress for Public Health in Rome, where she shared insights from the publication "Ethical Issues in Long-term Care in Low-, Middle- and High-Income Countries During the COVID-19 Pandemic." Additionally, Theresa was invited to speak to a graduating class of nurses at the Humber College Career Summit.

In her current role as the Provincial PoET Program Coordinator, Theresa focuses on spreading and implementing PoET’s ethics quality improvement project across long-term care homes throughout Ontario. Her responsibilities include supporting launch activities, providing training and education to staff and physicians, and facilitating discussions with residents and family members. Through adaptive leadership and change management skills, Theresa aims to align practices in long term care with Ontario’s Health Care Consent Act legislation, thereby reducing consent-related errors.

Theresa's commitment to resident-focused care, coupled with her extensive clinical experience underscores her dedication to enhancing health care delivery, research and ethical practices.

Dr. Jill Oliver brings a wealth of knowledge and expertise to her role as the Community Ethicist and PoET Project Lead. With a PhD in Philosophy from the University of Waterloo, she focuses on navigating complex ethical dilemmas, particularly within the realm of long-term care settings. Throughout her academic journey, Dr. Oliver has been committed to understanding and addressing critical issues surrounding consent, capacity, substitute decision making, and end-of-life care. Her academic pursuits include an Academic Fellowship in Clinical and Organizational Ethics from the University of Toronto Joint Centre for Bioethics, with hands-on experience gained in a number of health-care settings, including Mount Sinai, Toronto Rehab, Sunnybrook Hospital and Trillium Health Partners.

Dr. Oliver's dedication to applying her expertise in real-world settings is evident in her extensive internships in clinical ethics at renowned institutions such as the Baycrest Centre for Geriatric Care and Osler. These experiences have provided her with invaluable insights into the practical challenges faced by health care professionals and patients alike, informing her approach to ethical decision-making and quality improvement initiatives.

Currently, Dr. Oliver is spearheading the PoET Project. This groundbreaking initiative aims to enhance ethics-related quality improvement measures within the health care system, ensuring that patients receive the highest standard of care while upholding ethical principles and values.

Beyond her academic and professional accomplishments, Dr. Oliver is a lifelong learner, continuously seeking opportunities to expand her knowledge and skills. Her pursuit of further education, including a certificate in Elder Law from York University - Osgoode Hall Law School and a program in The Art and Practice of Adaptive Leadership from Harvard University, underscores her goal of excellence and innovation in her field.

Dr. Oliver's advocacy for ethical health care practices extends beyond academia. Her contributions have left an impact on the lives of patients, families and health care providers, fostering compassion, integrity and excellence. As a leading expert ethicist in long-term care settings, she is dedicated to advancing ethical health care practices and enhancing patient outcomes.

Dr. Angel Petropanagos is an Ethics Researcher at the Ethics Quality Improvement (EQI) Lab. With a PhD in philosophy from Western University, specializing in bioethics and feminist theory. She is deeply engaged at the intersection of ethics and health care decision-making. Her postdoctoral fellowship in bioethics at Novel Tech Ethics, Faculty of Medicine, Dalhousie University, solidified her expertise in the field.

As the Interim Communications Officer for the Canadian Bioethics Society and the Co-Managing Editor of Impact Ethics, Angel is committed to fostering dialogue and sharing insights within the bioethics community. She is also a co-founder and co-chair of the Ontario Practicing Healthcare Ethicists Community of Practice, demonstrating her dedication to advancing ethical practices in health care.

Dr. Petropanagos' clinical ethics work emphasizes a patient-centered approach and the importance of role clarity in health care decision-making. Her contributions extend beyond research and academia; she actively engages in creating practical tools and resources to support individuals, teams, and organizations in making ethically sound decisions.

Having completed Health Quality Ontario's IDEAS Advanced Learning Program, Dr. Petropanagos is at the forefront of developing, implementing, and scaling EQI projects such as the Checklist for Ethical and Legal Obligations and the PoET project. These initiatives exemplify her commitment to improving ethical decision-making processes in health care settings.

Dr. Petropanagos' publication record focuses on various topics in bioethics, including reproductive ethics, informed consent, medical assistance in dying, and health technology assessments. Her expertise is consulted in national and international policy discussions, where she provides valuable insights into complex ethical issues.

As a respected educator, Dr. Petropanagos has taught courses in bioethics, critical thinking, and philosophy at various institutions, including the University of Toronto and Humber College. She also contributes to clinical ethics education through guest lectures and workshops, ensuring that health care professionals are equipped with the knowledge and skills to navigate ethical challenges effectively.

Dr. Petropanagos' involvement in committees, working groups, and professional organizations reflects her commitment to shaping ethical practices and policies in health care. She will also be presenting Ethical Preparedness: AI and the Survivability of Research Ethics Boards at the upcoming International Conference on Clinical Ethics and Consultation and Canadian Bioethics Society in Montreal.

Dr. Salehi completed her undergraduate medical education at McGill University School of Medicine and her postgraduate training in Family Medicine at the University of Toronto, where she obtained her CCFP certification. Dr. Salehi further specialized in Emergency Medicine, completing the CCFP(EM) program at McGill University.

Complementing her clinical expertise, Dr. Salehi holds dual master's degrees, one in Health Policy and Administration from the Mailman School of Public Health at Columbia University and another in Public Health from the Dalla Lana School of Public Health at the University of Toronto. These academic pursuits have equipped her with a comprehensive understanding of health care systems and policy frameworks.

Throughout her career, Dr. Salehi has been active in research, particularly focusing on topics such as emergency department overcrowding, physician practice patterns, and diagnostic imaging utilization. As the Corporate Director of Research in Emergency Medicine at Osler, she led numerous research projects, resulting in several peer-reviewed publications, research abstracts, and conference presentations. Her research has been recognized through several awards, including the CAEP-CanVECTOR Research Abstract Award and the Michael Garron Hospital Publication Award.

In addition to her research endeavors, Dr. Salehi serves as an Assistant Clinical Professor at McMaster University and an Assistant Professor at the University of Toronto. Furthermore, she has held various administrative roles within Osler in the areas of Emergency Department flow and quality improvement, demonstrating her commitment to improving patient care and health care delivery systems.

Dr. Brandon Sheffield is an anatomical pathologist with expertise and a primary focus on molecular genetic pathology. His commitment to advancing personalized cancer treatments through the application of molecular genetics on an individual patient basis has significantly contributed to the field of oncology.

Dr. Sheffield's educational journey is marked by excellence and dedication, beginning with the President's Scholarship from the University of Western Ontario in September 2004. Driven by a passion genetics, he completed the Genetics program at Western University 2007 and earned his Doctor of Medicine from the University of Toronto in 2011. Subsequently, pursing a specialization in Pathology from The University of British Columbia in 2016.

His contributions have been acknowledged through numerous honors and awards. Notably, he was recognized as part of the Brampton Top 40 Under 40 in September 2019, a testament to his leadership and impact in the community. In 2016, he received the Changemaker Award from Doctors of BC, recognizing his significant contributions to health advocacy. His accomplishments in research have been internationally recognized, receiving the Young Investigator Award from the International Association for the Study of Lung Cancer in September 2015. Dr. Sheffield's commitment to clinical research in lung cancer was recognized with the Dutkevich Memorial Pathology Award from the University of Calgary in October 2010. He has received several other awards and honours.

During his time working with Osler, Dr. Sheffield highlighted his commitment to advancing healthcare through his role in acquiring Osler's newest next-generation sequencing technology, underscoring his dedication to advancing clinical research and enhancing patient care.

In the field of anatomical pathology Dr. Sheffield is continually pushing the boundaries of molecular genetic pathology to improve personalized cancer treatments and advance clinical research for the benefit of patients in the Brampton community and beyond.

Dr. Sohel Somani is a recognized ophthalmologist renowned for his expertise in medical retina and cataract surgery. His journey in the field of medicine began at the University of Toronto, where he earned his Doctor of Medicine degree after completing his pre-medical studies at the Faculty of Pharmacy. Dr. Somani then pursued a residency in Ophthalmology at the University of Toronto, followed by a fellowship in Medical Retina at the same institution.

Since 2004, Dr. Somani has been in private practice, where he has cultivated a specialized cataract surgery and medical retina practice. He serves as an attending surgeon at two regional hospitals and holds the position of Assistant Professor in the Department of Ophthalmology at the University of Toronto.

Throughout his career, Dr. Somani has been actively engaged in various research endeavors aimed at advancing ocular health. He is particularly involved with FORSEE Canada, a charitable organization dedicated to promoting research, education, and outreach in the field of ophthalmology.

In addition to his clinical and academic roles, Dr. Somani has demonstrated leadership in health care administration. He has served as the Surgical Lead at Osler's Peel Memorial and as the Medical Director of Uptown Eye Specialists. He has also held several divisional and committee leadership positions within the ophthalmology departments of various health care institutions.

Dr. Somani's dedication to excellence has been recognized through numerous awards and honors, including the John Gaby Prize for Best Fellow Research Paper at the University of Toronto. He is a member of several professional organizations, including the Canadian Retina Society, the American Society of Cataract and Refractive Surgery, and the Royal College of Physicians/Surgeons.

In addition to his clinical practice and research activities, Dr. Somani is committed to mentoring future generations of ophthalmologists. He has served as a lecturer at the University of Toronto and has been actively involved in post-graduate education and training programs.

Dr. Somani's passion for innovation and his dedication to improving patient care underscore his contributions to the field of ophthalmology. His commitment to excellence and his tireless pursuit of knowledge continue to inspire colleagues and patients alike.

Dr. Rahim Valani is a dedicated researcher with a passion for advancing medical education and emergency medical care. His primary focus revolves around developing innovative curricula and enhancing patient outcomes within emergency departments. Dr. Valani is deeply committed to molding future medical professionals, ensuring they possess the essential skills and knowledge required for success in the fast-paced world of health care.

In addition to his work in medical education, Dr. Valani engages in clinical research within emergency medical care. His research is specifically geared towards understanding and improving patient outcomes. He is heavily involved in developing predictive models that not only forecast patient trajectories but also assist in formulating effective treatment strategies.

Known for his enthusiasm and collaborative spirit, Dr. Valani is dedicated to driving advancements in health care through research. His goal is to develop outcomes and tools that significantly enhance patient care, benefiting both medical professionals and the patients they serve. At the core of his work lies the connection between educational theory and practical applications in the emergency room, fostering a more informed, efficient, and compassionate health care system.

Dr. Valani's qualifications include MD, CCFP-EM, FRCP(EM), M Med Ed, MBA, LLM (Health Law), and he is affiliated with prestigious institutions such as the University of Toronto and McMaster University.